Company Filing History:
Years Active: 2013
Title: Joacim Elmèn: Innovator in Antisense Oligomers
Introduction
Joacim Elmèn is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of medical research, particularly in the development of antisense oligomers. His work focuses on innovative solutions for treating medical disorders related to cholesterol levels.
Latest Patents
Joacim Elmèn holds a patent for "Antisense oligomers targeting PCSK9." This invention relates to oligomer compounds that target PCSK9 mRNA within cells, leading to a reduction in the expression of PCSK9. The reduction of PCSK9 expression is beneficial for treating certain medical disorders, such as hypercholesterolemia and related conditions. He has 1 patent to his name.
Career Highlights
Joacim Elmèn is currently associated with Santaris Pharma A/S, a company known for its innovative approaches in the pharmaceutical industry. His work at Santaris Pharma A/S has allowed him to explore and develop groundbreaking therapies that address critical health issues.
Collaborations
Throughout his career, Joacim has collaborated with esteemed colleagues, including Ellen Marie Straarup and Niels Fisker Nielsen. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Joacim Elmèn is a distinguished inventor whose work in antisense oligomers has the potential to transform the treatment of cholesterol-related disorders. His contributions to medical research continue to pave the way for innovative therapies that can improve patient outcomes.